Fig. 3From: Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-cateninKaplan-Meier curves for impact of the expression of Nek2B/β-catenin on disease-free survival (a) and overall survival (b). Log-rank P values are shown aboveBack to article page